ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Tetrahydrofuran → N-(9-fluorenylmethoxycarbonyl)-O-(4,4-bis(diethylphosphoryl)butyl)-L-tyrosine

HRID 39268
印刷

反応式

HRID 39268 の反応式
[CH:1]1[C:13]2[CH:12]([CH2:14][O:15][C:16]([NH:18][C@H:19]([C:28]([OH:30])=[O:29])[CH2:20][C:21]3[CH:26]=[CH:25][C:24]([OH:27])=[CH:23][CH:22]=3)=[O:17])[C:11]3[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=3)[C:5]=2[CH:4]=[CH:3][CH:2]=1.C1C=[CH:35][C:34]([P:37]([C:44]2[CH:49]=[CH:48][CH:47]=CC=2)[C:38]2[CH:43]=CC=CC=2)=CC=1.N(C(O[CH:61]([CH3:63])C)=O)=NC(OC(C)C)=O.CC[O:66][P:67](OCC)([CH:69](P(OCC)(OCC)=O)[CH2:70]CCO)=O.C1C[O:88]CC1>>[CH:1]1[C:13]2[CH:12]([CH2:14][O:15][C:16]([NH:18][C@H:19]([C:28]([OH:30])=[O:29])[CH2:20][C:21]3[CH:22]=[CH:23][C:24]([O:27][CH2:47][CH2:48][CH2:49][CH:44]([P:37]([CH2:34][CH3:35])([CH2:38][CH3:43])=[O:88])[P:67]([CH2:61][CH3:63])([CH2:69][CH3:70])=[O:66])=[CH:25][CH:26]=3)=[O:17])[C:11]3[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=3)[C:5]=2[CH:4]=[CH:3][CH:2]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 5

HCID 8028Tetrahydrofuran2 回HCID 11776TriphenylphosphineHCID 75555Diisopropyl diazene-1,2-dicarboxylateHCID 6957986(2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoic acidHCID 153967034,4-Bis(Diethoxyphosphoryl)butan-1-ol

生成物 1

HCID 86762026
N-(9-fluorenylmethoxycarbonyl)-O-(4,4-bis(diethylphosphoryl)butyl)-L-tyrosine
収率 43%

実験手順

A solution of 83 (664 mg, 1.44 mmol) and PPh3 (454 mg, 1.73 mmol) in THF (20 mL) was cooled in an ice-bath followed by the addition of diisopropyl azodicarboxylate (336 mg, 1.74 mmol). After a further 10 min a solution of 81 (500 mg, 1.44 mmol) in THF (5 mL) was added and the resulting solution was stirred while warming to room temperature overnight. The solvent was removed at reduced pressure and the crude material was purified by silica gel chromatography (0 to 10% methanol in ethyl acetate over 10 column volumes then 10 to 20% over 5 column volumes) using a Biotage Horizon™ apparatus resulting in the colourless liquid 84 (491 mg, 43%): 1H NMR (400 MHz, CDCl3) δ 1.33 (t, J=7.1, 6H), 1.34 (t, J=7.1, 6H), 1.43 (s, 9H), 2.04-2.18 (m, 4H), 2.37 (tt, J=6.3, 24.2, 1H), 2.98-3.07 (m, 2H), 3.92 (t, J=5.8, 2H), 4.14-4.22 (m, 8H), 4.33 (dd, J=7.1, 10.4, 1H), 4.43 (dd, J=7.2, 10.5, 1H), 4.50 (dd, J=6.0, 8.4, 1H), 5.24, (d, J=8.1, 1H), 6.78 (d, J=8.5, 2H), 7.04 (d, J=8.4, 2H), 7.28-7.33 (m, 2H), 7.40 (t, J=7.6, 2H), 7.77 (d, J=7.6, 2H): 31P (162 MHz, CDCl3) δ 24.74 (s, 2P).

後処理

  1. customThe solvent was removed at reduced pressure
  2. customthe crude material was purified by silica gel chromatography (0 to 10% methanol in ethyl acetate over 10 column volumes

出典と根拠

ORDレコード
ord-25c6d1d1a7234f55a4c27f12923f8b3f
出典データセット
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08524691B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート